Michael Tomas is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Feb 2021: U.S. Stem Cell, Inc. (Sunrise, FL — other health care — 2021; $468K reported sold to 18 investors).
What this means One deal on file with the SEC, filed Feb 2021. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Greg Knutson (1 shared filing), Mark Borman (1 shared filing), Sheldon Anderson (1 shared filing) and William Murphy, Jr. M.D. (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Michael Tomas and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Michael Tomas" (NY) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.